|
Iyengar, R V; Pawlik, C A; Krull, E J et al. (2001) Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Res 61:3045-52
|
|
Danks, M K; Morton, C L; Krull, E J et al. (1999) Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Clin Cancer Res 5:917-24
|
|
Guichard, S M; Danks, M K (1999) Topoisomerase enzymes as drug targets. Curr Opin Oncol 11:482-9
|
|
Potter, P M; Wolverton, J S; Morton, C L et al. (1998) Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. Cancer Res 58:3627-32
|
|
Wadkins, R M; Danks, M K; Horowitz, L et al. (1998) Characterization of topotecan-mediated redistribution of DNA topoisomerase I by digital imaging microscopy. Exp Cell Res 241:332-9
|
|
Guichard, S M; Morton, C L; Krull, E J et al. (1998) Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase. Clin Cancer Res 4:3089-94
|
|
Danks, M K; Morton, C L; Pawlik, C A et al. (1998) Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11. Cancer Res 58:20-2
|
|
Potter, P M; Wolverton, J S; Morton, C L et al. (1998) In situ subcellular localization of epitope-tagged human and rabbit carboxylesterases. Cytometry 32:223-32
|
|
Pawlik, C A; Houghton, P J; Stewart, C F et al. (1998) Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays. Clin Cancer Res 4:1995-2002
|
|
Danks, M K; Whipple, D O; McPake, C R et al. (1998) Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines. Cell Death Differ 5:678-86
|
Showing the most recent 10 out of 12 publications
